vs
Globe Life（GL）与Rollins, Inc.（ROL）财务数据对比。点击上方公司名可切换其他公司
Globe Life的季度营收约是Rollins, Inc.的1.7倍（$1.6B vs $906.4M），Globe Life净利率更高（17.3% vs 11.9%，领先5.4%），Rollins, Inc.同比增速更快（10.2% vs 5.3%），过去两年Globe Life的营收复合增速更高（4.1% vs 0.8%）
Globe Life Inc.（股票代码：GL）是总部位于美国得克萨斯州麦金尼的金融服务控股公司，在纽约证券交易所上市，通过旗下全资子公司开展业务，主营人寿保险、年金产品及补充健康保险产品。
Rollins, Inc.是北美知名虫害防治服务商，面向住宅及商业客户提供专业防控服务。公司依托Orkin、HomeTeam Pest Defense等多家全资子公司布局全球业务，覆盖北美、英国等市场，在民用及商用虫害治理领域具备深厚的行业积累与品牌优势。
GL vs ROL — 直观对比
营收规模更大
GL
是对方的1.7倍
$906.4M
营收增速更快
ROL
高出4.9%
5.3%
净利率更高
GL
高出5.4%
11.9%
两年增速更快
GL
近两年复合增速
0.8%
损益表 — Q1 FY2026 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $1.6B | $906.4M |
| 净利润 | $270.5M | $107.8M |
| 毛利率 | — | — |
| 营业利润率 | — | 16.1% |
| 净利率 | 17.3% | 11.9% |
| 营收同比 | 5.3% | 10.2% |
| 净利润同比 | — | 2.5% |
| 每股收益（稀释后） | $3.39 | $0.22 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收GLROL
| Q1 26 | $1.6B | $906.4M | ||
| Q4 25 | $1.5B | $912.9M | ||
| Q3 25 | $1.5B | $1.0B | ||
| Q2 25 | $1.5B | $999.5M | ||
| Q1 25 | $1.5B | $822.5M | ||
| Q4 24 | $1.5B | $832.2M | ||
| Q3 24 | $1.5B | $916.3M | ||
| Q2 24 | $1.4B | $891.9M |
净利润GLROL
| Q1 26 | $270.5M | $107.8M | ||
| Q4 25 | $266.1M | $116.4M | ||
| Q3 25 | $387.8M | $163.5M | ||
| Q2 25 | $252.7M | $141.5M | ||
| Q1 25 | $254.6M | $105.2M | ||
| Q4 24 | $255.2M | $105.7M | ||
| Q3 24 | $303.0M | $136.9M | ||
| Q2 24 | $258.4M | $129.4M |
毛利率GLROL
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 26.1% | — | ||
| Q2 24 | 23.3% | — |
营业利润率GLROL
| Q1 26 | — | 16.1% | ||
| Q4 25 | 21.7% | 17.5% | ||
| Q3 25 | 31.5% | 21.9% | ||
| Q2 25 | 21.2% | 19.8% | ||
| Q1 25 | 21.4% | 17.3% | ||
| Q4 24 | 21.3% | 18.1% | ||
| Q3 24 | 26.3% | 20.9% | ||
| Q2 24 | 23.5% | 20.4% |
净利率GLROL
| Q1 26 | 17.3% | 11.9% | ||
| Q4 25 | 17.5% | 12.8% | ||
| Q3 25 | 25.6% | 15.9% | ||
| Q2 25 | 17.1% | 14.2% | ||
| Q1 25 | 17.2% | 12.8% | ||
| Q4 24 | 17.4% | 12.7% | ||
| Q3 24 | 20.8% | 14.9% | ||
| Q2 24 | 17.9% | 14.5% |
每股收益（稀释后）GLROL
| Q1 26 | $3.39 | $0.22 | ||
| Q4 25 | $3.28 | $0.24 | ||
| Q3 25 | $4.73 | $0.34 | ||
| Q2 25 | $3.05 | $0.29 | ||
| Q1 25 | $3.01 | $0.22 | ||
| Q4 24 | $3.00 | $0.22 | ||
| Q3 24 | $3.44 | $0.28 | ||
| Q2 24 | $2.83 | $0.27 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $183.8M | $116.5M |
| 总债务越低越好 | — | $650.6M |
| 股东权益账面价值 | $6.1B | $1.4B |
| 总资产 | — | $3.2B |
| 负债/权益比越低杠杆越低 | — | 0.47× |
8季度趋势，按日历期对齐
现金及短期投资GLROL
| Q1 26 | $183.8M | $116.5M | ||
| Q4 25 | $314.7M | $100.0M | ||
| Q3 25 | $62.8M | $127.4M | ||
| Q2 25 | $116.7M | $123.0M | ||
| Q1 25 | $134.1M | $201.2M | ||
| Q4 24 | $85.0M | $89.6M | ||
| Q3 24 | $100.5M | $95.3M | ||
| Q2 24 | $100.6M | $106.7M |
总债务GLROL
| Q1 26 | — | $650.6M | ||
| Q4 25 | — | $486.1M | ||
| Q3 25 | — | $485.7M | ||
| Q2 25 | — | $485.3M | ||
| Q1 25 | — | $485.5M | ||
| Q4 24 | — | $395.3M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
股东权益GLROL
| Q1 26 | $6.1B | $1.4B | ||
| Q4 25 | $6.0B | $1.4B | ||
| Q3 25 | $5.7B | $1.5B | ||
| Q2 25 | $5.4B | $1.4B | ||
| Q1 25 | $5.4B | $1.4B | ||
| Q4 24 | $5.3B | $1.3B | ||
| Q3 24 | $4.6B | $1.3B | ||
| Q2 24 | $5.2B | $1.2B |
总资产GLROL
| Q1 26 | — | $3.2B | ||
| Q4 25 | $30.8B | $3.1B | ||
| Q3 25 | $30.5B | $3.2B | ||
| Q2 25 | $29.8B | $3.2B | ||
| Q1 25 | $29.7B | $2.9B | ||
| Q4 24 | $29.1B | $2.8B | ||
| Q3 24 | $29.6B | $2.8B | ||
| Q2 24 | $28.3B | $2.8B |
负债/权益比GLROL
| Q1 26 | — | 0.47× | ||
| Q4 25 | — | 0.35× | ||
| Q3 25 | — | 0.32× | ||
| Q2 25 | — | 0.34× | ||
| Q1 25 | — | 0.36× | ||
| Q4 24 | — | 0.30× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $118.4M |
| 自由现金流经营现金流 - 资本支出 | — | $111.2M |
| 自由现金流率自由现金流/营收 | — | 12.3% |
| 资本支出强度资本支出/营收 | — | 0.8% |
| 现金转化率经营现金流/净利润 | — | 1.10× |
| 过去12个月自由现金流最近4个季度 | — | $621.1M |
8季度趋势，按日历期对齐
经营现金流GLROL
| Q1 26 | — | $118.4M | ||
| Q4 25 | $350.6M | $164.7M | ||
| Q3 25 | $306.0M | $191.3M | ||
| Q2 25 | $307.9M | $175.1M | ||
| Q1 25 | $431.9M | $146.9M | ||
| Q4 24 | $336.9M | $188.2M | ||
| Q3 24 | $340.6M | $146.9M | ||
| Q2 24 | $374.1M | $145.1M |
自由现金流GLROL
| Q1 26 | — | $111.2M | ||
| Q4 25 | $330.1M | $159.0M | ||
| Q3 25 | $208.7M | $182.8M | ||
| Q2 25 | $295.0M | $168.0M | ||
| Q1 25 | $420.1M | $140.1M | ||
| Q4 24 | $321.9M | $184.0M | ||
| Q3 24 | $311.3M | $139.4M | ||
| Q2 24 | $356.5M | $136.4M |
自由现金流率GLROL
| Q1 26 | — | 12.3% | ||
| Q4 25 | 21.7% | 17.4% | ||
| Q3 25 | 13.8% | 17.8% | ||
| Q2 25 | 19.9% | 16.8% | ||
| Q1 25 | 28.4% | 17.0% | ||
| Q4 24 | 22.0% | 22.1% | ||
| Q3 24 | 21.4% | 15.2% | ||
| Q2 24 | 24.8% | 15.3% |
资本支出强度GLROL
| Q1 26 | — | 0.8% | ||
| Q4 25 | 1.3% | 0.6% | ||
| Q3 25 | 6.4% | 0.8% | ||
| Q2 25 | 0.9% | 0.7% | ||
| Q1 25 | 0.8% | 0.8% | ||
| Q4 24 | 1.0% | 0.5% | ||
| Q3 24 | 2.0% | 0.8% | ||
| Q2 24 | 1.2% | 1.0% |
现金转化率GLROL
| Q1 26 | — | 1.10× | ||
| Q4 25 | 1.32× | 1.41× | ||
| Q3 25 | 0.79× | 1.17× | ||
| Q2 25 | 1.22× | 1.24× | ||
| Q1 25 | 1.70× | 1.40× | ||
| Q4 24 | 1.32× | 1.78× | ||
| Q3 24 | 1.12× | 1.07× | ||
| Q2 24 | 1.45× | 1.12× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
GL
| Life premium | $853.2M | 55% |
| Health premium | $416.9M | 27% |
| Other | $289.5M | 19% |
ROL
暂无分部数据
